Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Authors / Fiona Greer

Fiona Greer

Fiona is Life Sciences Global Director at SGS Labs. She has always been attracted to the investigative nature of analytical science, initially studying Forensic Science and completing a PhD in Protein Chemistry looking at plant toxins. In the early 1980s, she joined a pioneering start-up company to utilize biological mass spectrometry to interrogate the structure of proteins and glycoproteins for the emerging biotechnology industry. With over 35 years of experience in this field, she has seen biological drugs, particularly monoclonal antibodies, become the blockbusters of the pharma world.

  • Contributions
Fields & Applications Pharma and Biopharma

Biosimilar Breakdown

September 16, 2016

The biopharmaceutical industry’s excitement for biosimilars has demanded the very best – and more – from analytical scientists and their tools. Here, Fiona Greer – long-time specialist in biopharmaceutical analysis – describes the need for instrumental orthogonality and the drive towards “fingerprint-like” comparative data. And Pat and Koen Sandra discuss the power of a rising analytical star in the field: two-dimensional liquid chromatography.After finally breaking into the US market, biosimilars have created a real buzz in the industry, but demonstrating similarity can be daunting to say the least. Here, I share the tools of the trade and discuss the role of analytical science.

1 min read

Biosimilar Breakdown

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.